The “In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2017” analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Japan, BRIC and Rest of the World.
The global market
was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by
2017, at a CAGR of 7% from 2012 to 2017. This market is primarily driven
by rising incidences of chronic and infectious diseases in emerging economies,
a rapidly aging population, the rise in point-of-care testing, and the rising
importance of personalized medicine. However, factors such as stringent
regulatory frameworks and a shortage of budget and labor are restraining the
growth of the market.
Get Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=703
The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, this market has segments like instruments, reagents, data management software/hardware, and services.
Based on applications, this market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=703
The key players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickson and Company (U.S.), Siemens Healthcare (Germany), Diagnostica Stago SAS (France), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ARKRAY, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), DiaSorin S.p.A. (Italy), Sysmex Corporation (Japan), bioMérieux (France), HORIBA, Ltd. (Japan), and Alere, Inc. (U.S.).
Browse related reports:
Immunoassay Market [Technology (Enzyme,
Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents,
Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End
Users (Hospitals, Laboratory, Academics)] – Global Forecast to 2018
Molecular Diagnostics Market - Technologies
[PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification,
Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic
Testing, Blood Screening, Microbiology] Global Opportunities, Competitor
Analysis & Forecasts to 2017
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets